Thursday, Oct 9, 2025 · SEC filings
What the smart money revealed on Oct 9
154 insider filings came in. We hid 29 planned (10b5-1) sellers and 60 people whose filings were routine, like grants and tax withholding.
5 insiders at CPS Technologies (CPSH) bought $201K of stock
Roles: CEO, CFO, Director. Several insiders buying in the same few days is rare.
3 insiders at Zenas BioPharma (ZBIO) bought $11.8M of stock
Roles: Officer, Director. Several insiders buying in the same few days is rare.
Agree Realty (ADC) Director John Rakolta bought $1.77M
25,154 shares on the open market. Not a grant or an option exercise. Their past buys: 4 of 6 checked quarters beat the typical stock 6 months later.
aTYR Pharma INC (ATYR) Director Paul Schimmel bought $913K
1M shares on the open market. Not a grant or an option exercise.
Zivo Bioscience (ZIVO) Director Christopher Maggiore bought $284K
23,682 shares on the open market. Not a grant or an option exercise.
Conagra Brands (CAG) Director Thomas Brown bought $187K
10,000 shares on the open market. Not a grant or an option exercise.
Strategy (MSTR) EVP & General Counsel Wei-Ming Shao sold $10.7M
Not marked as a planned 10b5-1 sale. Sold 70% of the shares they held directly. Still holds 12,726 shares.
SailPoint (SAIL) CEO Mark McClain sold $10.5M
Not marked as a planned 10b5-1 sale. Sold 6% of the shares they held directly. Still holds 7.2M shares.
Disc Medicine (IRON) Director Kevin Bitterman sold $6.31M
Not marked as a planned 10b5-1 sale. Sold 15% of the shares they held directly. Still holds 500,621 shares.
Show 15 more real buys
Show 16 more real sales
13F season
Holdings as of Sep 30, 2025 are due Nov 14
81 funds have filed so far. 74 filed for the quarter before.
Biggest real insider buys, Oct 3–9
Open-market buys by officers and directors, filed in the 7 days up to Oct 9.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.